Skip to main content
. 2017 Dec 4;12(12):e0188642. doi: 10.1371/journal.pone.0188642

Table 5. Median differences of ARAT, FMA-UEand DASH scores from baseline (T0) to Post (T3) and to the 6-week follow-up visit (T4).

Test Time M-TOT (N = 21) C-TOT (N = 24) p-value (treatment) p-value (visit) p-value (treatment*visit) p-value (visit contrasts)
N Median IQR N Median IQR
ARAT T1 20 1.0 0.0;6.5 23 0.0 0.0;2.0 0.78 0.0006 0.13
T2 21 2.0 0.0;10.0 21 0.0 0.0;4.0
T3 21 4.0 0.0;14.0 24 1.5 0.0;5.0 T0-T3: <0.0001
T4 21 4.0 0.0;14.0 24 3.0 0.0;4.0 T3-T4: 0.62
FMA-UE T3 21 5.0 2.0;14.0 24 3.5 0.5;6.5 0.37 <0.0001 0.13 T0-T3: <0.0001
T4 21 7.0 2.0;15.0 24 4.0 0.0;7.0 T3-T4: 0.07
DASH T3 21 -6.8 -13.6;-2.3 22 -4.5 -13.6;0 0.10 <0.0001 0.81 T0-T3: <0.0001
T4 21 -10.5 -18.2;-2.3 19 -16.5 -23.0;0 T3-T4: 0.31

M-TOT: Myoelectric control of functional electrical stimulation-task oriented training; C-TOT: control-task oriented training; IQR: interquartile range. ARAT: action research arm test; FMA-UE: Fugl Meyer assessment for the upper limbs; DASH: disability of the arm, shoulder and hand questionnaire.T1: after 8 rehabilitation sessions; T2: after 16 rehabilitation sessions; T3: post-treatment visit (after 25 rehabilitation sessions, 6–7 weeks).; T4: 6-week follow-up visit. p-values for treatment effect (differences between treatment arms), visit effect (differences between visits), treatment*visit interaction (differences in the change over time between treatment arms) and visit contrasts (change between selected visit times) were obtained from a multivariable repeated measures mixed model, adjusting by stroke chronicity and rehabilitation center.